Gene · 129607
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unlocking the Potential of Stroke Blood Biomarkers: Early Diagnosis, Ischemic vs. Haemorrhagic Differentiation and Haemorrhagic Transformation Risk: A Comprehensive Review. | Int J Mol Sci | 2023 | 37511304 | PubTator, text mining | PubMed |
| Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A). | Biomolecules | 2023 | 37509196 | PubTator, text mining | PubMed |
| Plasma proteome of growing tumors. | Sci Rep | 2023 | 37500700 | PubTator, text mining | PubMed |
| VBASS enables integration of single cell gene expression data in Bayesian association analysis of rare variants. | Commun Biol | 2023 | 37491581 | PubTator, text mining | PubMed |
| Effects of multiple stressors on pancreatic human islets proteome reveal new insights into the pathways involved. | Proteomics | 2023 | 37489002 | PubTator, text mining | PubMed |
| The secretome as a biomarker and functional agent in heart failure. | J Cardiovasc Aging | 2023 | 37484982 | PubTator, text mining | PubMed |
| A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies. | Front Immunol | 2023 | 37475860 | PubTator, text mining | PubMed |
| Effectively utilizing publicly available databases for cancer target evaluation. | NAR Cancer | 2023 | 37457379 | PubTator, text mining | PubMed |
| CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses. | iScience | 2023 | 37456846 | PubTator, text mining | PubMed |
| Naringin from Coffee Inhibits Foodborne Aspergillus fumigatus via the NDK Pathway: Evidence from an In Silico Study. | Molecules | 2023 | 37446851 | PubTator, text mining | PubMed |
| Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review. | Int J Mol Sci | 2023 | 37446307 | PubTator, text mining | PubMed |
| The Genetics of Primary Familial Brain Calcification: A Literature Review. | Int J Mol Sci | 2023 | 37446066 | PubTator, text mining | PubMed |
Extensive Bioinformatics Analyses Reveal a Phylogenetically Conserved Winged Helix (WH) Domain (Zτ) of Topoisomerase IIα, Elucidating Its Very High Affinity for Left-Handed Z-DNA and Suggesting Novel Putative Functions. | Int J Mol Sci | 2023 | 37445918 | PubTator, text mining | PubMed |
| Ribonucleotide synthesis by NME6 fuels mitochondrial gene expression. | EMBO J | 2023 | 37439264 | PubTator, text mining | PubMed |
| Advanced methods and novel biomarkers in autoimmune diseases ‑ a review of the recent years progress in systemic lupus erythematosus. | Front Med (Lausanne) | 2023 | 37425332 | PubTator, text mining | PubMed |
| Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. | PLoS One | 2023 | 37418424 | PubTator, text mining | PubMed |
| Metabolic protein kinase signalling in neuroblastoma. | Mol Metab | 2023 | 37414143 | PubTator, text mining | PubMed |
| Health service utilisation for acute respiratory infections in infants graduating from the neonatal intensive care unit: a population-based cohort study. | BMC Pediatr | 2023 | 37393229 | PubTator, text mining | PubMed |
| Vpx requires active cellular dNTP biosynthesis to effectively counteract the anti-lentivirus activity of SAMHD1 in macrophages. | J Biol Chem | 2023 | 37390988 | PubTator, text mining | PubMed |
| Automated identification of patient subgroups: A case-study on mortality of COVID-19 patients admitted to the ICU. | Comput Biol Med | 2023 | 37356293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/129607/papers?page=9